Christopher Brett Primiano - Net Worth and Insider Trading
Christopher Brett Primiano Net Worth
The estimated net worth of Christopher Brett Primiano is at least $1,374 dollars as of 2025-07-14. Christopher Brett Primiano is the EVP, CBO, GC & Secretary of Karyopharm Therapeutics Inc and owns about 302 shares of Karyopharm Therapeutics Inc (KPTI) stock worth over $1,374. Details can be seen in Christopher Brett Primiano's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher Brett Primiano has not made any transactions after 2020-12-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher Brett Primiano
Christopher Brett Primiano Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher Brett Primiano owns 2 companies in total, including Karyopharm Therapeutics Inc (KPTI) , and Aura Biosciences Inc (AURA) .
Click here to see the complete history of Christopher Brett Primiano’s form 4 insider trades.
Insider Ownership Summary of Christopher Brett Primiano
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc | 2020-12-01 | VP & Gen Counsel & Secretary |
| AURA | Aura Biosciences Inc | 2021-10-28 | Chief Business Officer |
Christopher Brett Primiano Latest Holdings Summary
Christopher Brett Primiano currently owns a total of 1 stock. Christopher Brett Primiano owns 302 shares of Karyopharm Therapeutics Inc (KPTI) as of December 1, 2020, with a value of $1,374.
Latest Holdings of Christopher Brett Primiano
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc | 2020-12-01 | 302 | 4.55 | 1,374 |
Holding Weightings of Christopher Brett Primiano
Christopher Brett Primiano Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher Brett Primiano has made a total of 4 transactions in Karyopharm Therapeutics Inc (KPTI) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Karyopharm Therapeutics Inc is the sale of 9,137 shares on December 1, 2020, which brought Christopher Brett Primiano around $2 Million.
Insider Trading History of Christopher Brett Primiano
- 1
Christopher Brett Primiano Trading Performance
Christopher Brett Primiano Ownership Network
Ownership Network List of Christopher Brett Primiano
Ownership Network Relation of Christopher Brett Primiano
Christopher Brett Primiano Owned Company Details
What does Karyopharm Therapeutics Inc do?
Who are the key executives at Karyopharm Therapeutics Inc?
Christopher Brett Primiano is the VP & Gen Counsel & Secretary of Karyopharm Therapeutics Inc. Other key executives at Karyopharm Therapeutics Inc include director & President and CEO Richard A. Paulson , EVP & Chief Medical Officer Reshma Rangwala , and EVP & Chief Development Officer Stuart Poulton .
Karyopharm Therapeutics Inc (KPTI) Insider Trades Summary
Over the past 18 months, Christopher Brett Primiano made no insider transaction in Karyopharm Therapeutics Inc (KPTI). Other recent insider transactions involving Karyopharm Therapeutics Inc (KPTI) include a net sale of 160,282 shares made by Richard A. Paulson , a net sale of 48,301 shares made by Michael Mason , and a net sale of 40,658 shares made by Stuart Poulton .
In summary, during the past 3 months, insiders sold 655 shares of Karyopharm Therapeutics Inc (KPTI) in total and bought 0 shares, with a net sale of 655 shares. During the past 18 months, 162,737 shares of Karyopharm Therapeutics Inc (KPTI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 162,737 shares.
Karyopharm Therapeutics Inc (KPTI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Karyopharm Therapeutics Inc Insider Transactions
Christopher Brett Primiano Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher Brett Primiano. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Christopher Brett Primiano's mailing address is: Newton Ma 02459.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
